Benaroya Research Institute at Virginia Mason (BRI) is an international leader in immune system and autoimmune disease research translating discoveries to real life applications. BRI is one of the few research institutes in the world dedicated to finding causes and cures to eliminate autoimmune diseases including Type 1 diabetes, arthritis, lupus, multiple sclerosis, scleroderma and many others.
This program focuses on identifying the causes and cures of Type 1 (autoimmune) diabetes through basic and clinical research.
This program's mission is to understand the relationship between the immune system and diseases and to design new therapies.
This program acts as an interface between the laboratory researchers, clinicians and patients to translate scientific knowledge into clinical trials.
This program focuses on diseases of the body’s tissues, heart and blood vessels—and conducts basic and translational research.
This program conducts clinical trials of new therapeutics, and studies clinical outcomes.
Learn about our researchers.
